<VariationArchive VariationID="5956" VariationName="NM_006996.3(SLC19A2):c.725del (p.Pro242fs)" VariationType="Deletion" Accession="VCV000005956" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2017-11-25" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20995" VariationID="5956">
      <GeneList>
        <Gene Symbol="SLC19A2" FullName="solute carrier family 19 member 2" GeneID="10560" HGNC_ID="HGNC:10938" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169463909" stop="169485970" display_start="169463909" display_stop="169485970" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169433146" stop="169455207" display_start="169433146" display_stop="169455207" Strand="-" />
          </Location>
          <OMIM>603941</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006996.3(SLC19A2):c.725del (p.Pro242fs)</Name>
      <CanonicalSPDI>NC_000001.11:169477236:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169477237" stop="169477237" display_start="169477237" display_stop="169477237" variantLength="1" positionVCF="169477236" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169446475" stop="169446475" display_start="169446475" display_stop="169446475" variantLength="1" positionVCF="169446474" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P242fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.169446478del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.169446478del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.169477240del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.169477240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008255.1" sequenceAccession="NG_008255" sequenceVersion="1" change="g.13734del">
            <Expression>NG_008255.1:g.13734del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006996.3" sequenceAccession="NM_006996" sequenceVersion="3" change="c.725del" MANESelect="true">
            <Expression>NM_006996.3:c.725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008927.1" sequenceAccession="NP_008927" sequenceVersion="1" change="p.Pro242fs">
            <Expression>NP_008927.1:p.Pro242fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319667.1" sequenceAccession="NM_001319667" sequenceVersion="1" change="c.205-7051del">
            <Expression>NM_001319667.1:c.205-7051del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603941.0002" DB="OMIM" />
        <XRef Type="rs" ID="1571537544" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006996.3(SLC19A2):c.725del (p.Pro242fs) AND Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" Accession="RCV000006320" Version="3">
        <ClassifiedConditionList TraitSetID="1649">
          <ClassifiedCondition DB="MedGen" ID="C0342287">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006996.3(SLC19A2):c.725del (p.Pro242fs) AND not provided" Accession="RCV003555937" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-19" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-11-25" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10391221</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10391223</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10874303</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1649" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4256" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ElementValue>
                <XRef ID="Thiamine+responsive+megaloblastic+anemia+syndrome/7055" DB="Genetic Alliance" />
                <XRef ID="237617006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA, DIABETES MELLITUS, AND DEAFNESS TYPE)</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine-responsive anemia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rogers syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine-responsive myelodysplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TRMA</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THMD1</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9210" />
                <XRef ID="9210" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic and anemia can recur if treatment is withdrawn. Progressive sensorineural hearing loss often occurs early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may reduce insulin requirement and delay onset of diabetes in some individuals.</Attribute>
                <XRef ID="NBK1282" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301459</ID>
                <ID Source="BookShelf">NBK1282</ID>
              </Citation>
              <XRef ID="49827" DB="Orphanet" />
              <XRef ID="C0342287" DB="MedGen" />
              <XRef ID="MONDO:0009575" DB="MONDO" />
              <XRef Type="MIM" ID="249270" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26502" SubmissionDate="2017-11-22" DateLastUpdated="2017-11-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603941.0002_THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME" title="SLC19A2, 1-BP DEL, 724C_THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME" />
        <ClinVarAccession Accession="SCV000026502" DateUpdated="2017-11-25" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 2 Israeli families with thiamine-responsive megaloblastic anemia syndrome (TRMA; 249270), Labay et al. (1999) found a homozygous 1-bp deletion (724delC) in exon 2 of the SLC19A2 gene, causing a frameshift at codon 242 and creating a stop at codon 259.</Attribute>
              <Citation>
                <ID Source="PubMed">10391221</ID>
              </Citation>
              <XRef DB="OMIM" ID="249270" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A2" />
          </GeneList>
          <Name>SLC19A2, 1-BP DEL, 724C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 724C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603941.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7977718" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4820988|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293790" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10391221</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10391221</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10391223</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10874303</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 5956). This premature translational stop signal has been observed in individual(s) with thiamine-responsive megaloblastic anemia (PMID: 10391221). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro242Glnfs*18) in the SLC19A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A2 are known to be pathogenic (PMID: 10391221, 10391223, 10874303).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.169446475del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26502" TraitType="Disease" MappingType="Name" MappingValue="THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0342287" Name="Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7977718" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

